Immunohistochemical classification divides breast cancers into five molecular subtypes according to the expression of their hormonal receptors: estrogen receptor (ER) and progesterone receptor (PR), human epidermal growth factor receptor (HER2), and Ki-67. This evidence concerns the gene ESR1 and breast carcinoma.